Filing Details
Aptevo Therapeutics Inc. (NASDAQ:APVO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:APVO
Aptevo Therapeutics Inc. (APVO) Files Quarterly Report for Q0
Aptevo Therapeutics Inc. (NASDAQ:APVO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
Aptevo Therapeutics Inc. (NASDAQ:APVO) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Aptevo Therapeutics Inc. (NASDAQ: APVO) filed its quarterly report (Form 10-Q) with the SEC on August 14, 2026.
- The company's stock trades at $2.94 with a market capitalization of $12.0 million.
- The 10-Q filing contains unaudited financial statements and management commentary on recent performance, including updated risk factors and changes in business conditions.
Market Context
Aptevo Therapeutics Inc.'s stock currently trades at $2.94 with a market capitalization of $12.0M.
The 10-Q provides Aptevo Therapeutics Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Aptevo Therapeutics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View APVO Stock Page
Frequently Asked Questions
Where can I read APVO's SEC filings?
Browse all filings on our APVO SEC filings page.
What types of SEC filings does Aptevo Therapeutics Inc. file?
Public companies like Aptevo Therapeutics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.